CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 97,712 enrolled
Drug / intervention
Comfort Talk®behavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01563198
NCT01563198N/ACompleted

Amelioration of Claustrophobia and Disruptive Patient Motion in MR Imaging

Hypnalgesics, LLC·interventional·Posted Mar 26, 2012·Updated Apr 14, 2017

In Brief

A clinical study evaluating Comfort Talk® for Claustrophobia and Complication of Diagnostic Procedure. Completed, enrolled 97,712 participants across 4 sites.

Detailed Summary

Annually, an estimated 700,000 patients do not complete their scheduled MRI scans because of claustrophobia or inability to hold still. Training staff working in MRI facilities to provide Comfort Talk® promises to enable patients to complete and obtain high quality imaging without medication, which will increase comfort and reduce sedation risks for the patients, and increase efficiency and reduce loss of revenue for the facilities.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States

Timeline

N/ACompletedFinished
201220132014201520162017201820192020202120222023202420252026
First PostedMar 26, 2012
Enrollment StartAug 1, 2011
Primary CompletionJul 1, 2015
Study CompletionFeb 17, 2016
TodayJul 2, 2026
Enrollment to primary: 3.9 yearsPosted 14.3 years ago

Interventions

Comfort Talk®behavioral

Personnel of MRI units will be trained in advanced rapport skills, patient-centered and hypnoidal language, correct use of suggestions and skills of tension diffusion. This will entail 16 hrs class room work, additional on-site post-training support, and access to a post-training support web module resulting in at least 20 hrs training.